Your browser doesn't support javascript.
loading
Anti-PD-1 Therapy plus Chemotherapy and/or Bevacizumab as Second Line or later Treatment for Patients with Advanced Non-Small Cell Lung Cancer.
Zhang, Fan; Huang, Di; Li, Tao; Zhang, Sujie; Wang, Jinliang; Zhang, Yuzi; Wang, Guoqiang; Zhao, Zhengyi; Ma, Junxun; Wang, Lijie; Sun, Danyang; Cui, Pengfei; Cai, Shangli; Jiao, Shunchang; Zhao, Lei; Hu, Yi.
Afiliação
  • Zhang F; Department of Oncology, Chinese PLA General Hospital, PLA School of Medicine, Beijing, People's Republic of China.
  • Huang D; School of medicine, Nankai University, Tianjin, People's Republic of China.
  • Li T; Department of Oncology, Chinese PLA General Hospital, PLA School of Medicine, Beijing, People's Republic of China.
  • Zhang S; Department of Oncology, Chinese PLA General Hospital, PLA School of Medicine, Beijing, People's Republic of China.
  • Wang J; Department of Oncology, Chinese PLA General Hospital, PLA School of Medicine, Beijing, People's Republic of China.
  • Zhang Y; Department of Oncology, Chinese PLA General Hospital, PLA School of Medicine, Beijing, People's Republic of China.
  • Wang G; The Medical Department, 3D Medicines Inc., Shanghai, People's Republic of China.
  • Zhao Z; The Medical Department, 3D Medicines Inc., Shanghai, People's Republic of China.
  • Ma J; The Medical Department, 3D Medicines Inc., Shanghai, People's Republic of China.
  • Wang L; Department of Oncology, Chinese PLA General Hospital, PLA School of Medicine, Beijing, People's Republic of China.
  • Sun D; Department of Oncology, Chinese PLA General Hospital, PLA School of Medicine, Beijing, People's Republic of China.
  • Cui P; Department of Oncology, Chinese PLA General Hospital, PLA School of Medicine, Beijing, People's Republic of China.
  • Cai S; Department of Oncology, Chinese PLA General Hospital, PLA School of Medicine, Beijing, People's Republic of China.
  • Jiao S; The Medical Department, 3D Medicines Inc., Shanghai, People's Republic of China.
  • Zhao L; Department of Oncology, Chinese PLA General Hospital, PLA School of Medicine, Beijing, People's Republic of China.
  • Hu Y; National Clinical Research Center for Normal Aging and Geriatric & The Key Lab of Normal Aging and Geriatric, Institute of Geriatric, PLA General Hospital, Beijing, People's Republic of China.
J Cancer ; 11(3): 741-749, 2020.
Article em En | MEDLINE | ID: mdl-31942197
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article